Solace Behavioral Health
Solace Behavioral Health is a private psychiatric practice operating three clinics in Florida's Tampa Bay area, delivering advanced treatments for treatment-resistant depression, OCD, anxiety, and addiction, including BrainsWay Deep TMS, Spravato, IV Ketamine, counseling, and IOP.
- Company typePrivate
- Founded2012
- HeadquartersBrooksville, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Solace Behavioral Health does
Solace Behavioral Health is a privately held outpatient psychiatric practice founded in 2012 and headquartered in Brooksville, Florida. The firm operates three physical clinic locations across the Tampa Bay region (Brooksville, New Port Richey, and Tampa) and treats patients with major depressive disorder, treatment-resistant depression (TRD), OCD, anxiety, PTSD, substance use disorders, and co-occurring mental health conditions. Its primary patient segment is adults with treatment-resistant depression who have failed multiple medication trials.
The practice's core technology stack centers on FDA-cleared neuromodulation and controlled pharmacotherapy modalities rather than proprietary software. The flagship offering is BrainsWay Deep TMS using H-Coil technology — H1 coils for depression and anxiety and H7 coils for OCD — adopted in 2019 after operating on NeuroStar TMS since 2012. Spravato (esketamine) is delivered at all REMS-certified locations under supervised conditions, and IV Ketamine has been offered since 2015. These are complemented by conventional psychiatric services: comprehensive psychiatric evaluation, medication management, counseling delivered via 20+ modalities (including EMDR, ART, RRT), Medication-Assisted Treatment with Suboxone, detox consultations, an Intensive Outpatient Program (launched September 2020), and group therapy.
The business model is professional-services billing reimbursed primarily through insurance (Medicare and commercial plans), with the company directly billing payers. Go-to-market is sales-led direct patient acquisition through phone inquiries, online appointment requests, healthcare-provider referrals, and content-marketing and SEO around treatment-resistant depression and TMS. There is no evidence of external investment, M&A activity, or non-organic expansion; the practice appears to be entirely owner-operated and self-funded.
Solace Behavioral Health firmographics
Firmographics- Name
- Solace Behavioral Health
- Legal name
- Solace Behavioral Health
- Website
- https://solacebehavioralhealth.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Solace Behavioral Health is a private psychiatric practice operating three clinics in Florida's Tampa Bay area, delivering advanced treatments for treatment-resistant depression, OCD, anxiety, and addiction, including BrainsWay Deep TMS, Spravato, IV Ketamine, counseling, and IOP.
- Ownership category
- akta.pro rank
Solace Behavioral Health industry classification
Industry- Product category
- Behavioral Health Services
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)
- akta.pro secondary industries
- Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG), Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)
Keywords
Where Solace Behavioral Health is headquartered
LocationHeadquarters
- HQ city
- Brooksville
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Solace Behavioral Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Psychiatric Services: Comprehensive psychiatric evaluations, medication management, and ongoing psychiatric care. Billed through insurance or self-pay.
- TMS Therapy: Transcranial Magnetic Stimulation treatment sessions for depression, OCD, and other conditions. Typically 30 sessions over 6-8 weeks. Covered by most insurance plans including Medicare.
- Spravato Treatment: Esketamine treatment for treatment-resistant depression. Administered twice weekly for approximately 6 weeks under supervised conditions. Insurance-covered.
- Ketamine Therapy: IV Ketamine infusions for treatment-resistant depression. Administered in controlled clinical setting.
- Counseling Services: Individual therapy using over 20 modalities including EMDR, ART, RRT. Therapy-focused approach combined with medication management.
- Addiction Treatment and IOP: Addiction treatment including MAT with Suboxone, detox consultations, intensive outpatient program (IOP), and group therapy.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Insurance-based psychiatric and therapy services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Solace Behavioral Health product offering
Product offeringCore offering
Solace Behavioral Health is a psychiatric practice operating three clinics in Florida that delivers outpatient mental health and addiction treatment. Core offerings include Transcranial Magnetic Stimulation (TMS) using NeuroStar and BrainsWay Deep TMS systems, Spravato (esketamine) intranasal therapy, IV Ketamine infusions, psychiatric evaluation and medication management, individual counseling across 20+ modalities, addiction treatment with MAT (Suboxone), detox consultation, an Intensive Outpatient Program (IOP), group therapy, and meditation guidance.
Product overview
Solace Behavioral Health is a behavioral health treatment center offering a comprehensive portfolio of mental health services. The core treatment offerings include NeuroStar TMS Therapy (used since 2012) and Brainsway Deep TMS Therapy (adopted in 2019), which are non-invasive neuromodulation treatments for depression and OCD. The practice also offers Spravato (esketamine) and IV Ketamine for treatment-resistant depression. These are complemented by traditional psychiatric services including psychiatric evaluation, medication management, counseling with over 20 therapeutic modalities, addiction treatment with MAT, detox services, intensive outpatient program (IOP), group therapy, and meditation services. The TMS therapies serve as the primary advanced treatment offerings, while ketamine-based treatments represent rapid-acting alternatives for treatment-resistant cases.
Differentiator
Problem solved
Functional benefit
Products and services
- NeuroStar TMS Therapy Non-invasive Transcranial Magnetic Stimulation therapy using the NeuroStar system to treat depression by delivering magnetic pulses to brain regions associated with mood regulation; administered daily over 4-6 weeks for patients with treatment-resistant depression.
- BrainsWay Deep TMS Therapy Advanced Deep Transcranial Magnetic Stimulation using BrainsWay's proprietary H-Coil technology offering deeper and broader brain stimulation than traditional figure-8 TMS coils. The H1 coil treats depression and anxiety; the H7 coil is FDA-cleared for OCD.
- Spravato (Esketamine) Treatment
Quantifiable outcome
- 1 out of 3 patients free of depression symptoms completely
- +4 more outcomes
Companies that use Solace Behavioral Health
Customer profileSegments4 records
Ideal customer profiles3 records
Solace Behavioral Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Solace Behavioral Health partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core, secondary and minor.
- BrainsWaycoreBrainsWay is the provider of Deep TMS technology used at Solace Behavioral Health. The practice switched from NeuroStar to BrainsWay system in 2019. Solace offers both H1 Coil for Depression and Anxiety and H7 Coil for OCD. They are one of the few practitioners to have upgraded to this new system in the Tampa Bay Area and are the ONLY provider with the OCD coil in two locations.
- NeuroStar (Neuronetics)secondaryNeuroStar Advanced TMS Therapy system provider. Solace worked with the NeuroStar System since 2012 before switching to BrainsWay in 2019. NeuroStar TMS uses transcranial magnetic stimulation targeting key areas of the brain underactive in people with depression.
- Spravato (Janssen Pharmaceuticals)coreSpravato (Esketamine) REMS certified treatment center. Solace has been a Spravato Treatment Center for around 5 years. Spravato is the first and only FDA-approved NMDA receptor antagonist for treatment-resistant depression, derived from Ketamine but administered intranasally.
- Detox Facility PartnersminorReferral partnerships with detox facilities for severe addiction cases requiring hospitalization. Solace refers patients to partners for detox but provides MAT with Suboxone and addiction counseling at their locations. Facilities referenced under Resources and Community Resources on website.
Scale indicators6 records
Recent moves5 records
Expansion highlights4 records
Solace Behavioral Health competitors and assessment
Company assessmentRegional players
- Pasadena Recovery Center: Addiction and co-occurring mental health treatment provider offering MAT, detox, and outpatient services. Comparable on the SUD/dual-diagnosis segment Solace addresses.
- Behavioral Health of the Palm Beaches: Florida-based behavioral health provider offering psychiatric services, addiction treatment, and outpatient programs. Comparable regional outpatient behavioral health model, though serving South Florida rather than Tampa Bay.
- CenterPointe Health: Outpatient behavioral health provider offering psychiatric services, counseling, addiction treatment, and MAT. Comparable service mix to Solace's IOP, MAT, and counseling offerings.
Emerging players
- Talkiatry: Tech-enabled psychiatric practice providing medication management and therapy, with growing in-person footprint. Comparable outpatient psychiatry model with partial overlap on TMS-adjacent patients.
- Charlie Health: Virtual and in-person intensive outpatient (IOP) provider for teens and young adults with mental health and substance use conditions. Comparable on IOP modality and SUD treatment focus.
- Brightside Health: Telehealth-first mental health provider treating depression and anxiety including medication management. Partial overlap on treatment-resistant depression patient segment, though delivery is virtual rather than clinic-based.
- Cerebral: Telehealth mental health platform providing medication management and therapy for anxiety and depression. Partial overlap on treatment-resistant depression patient pool, though predominantly online delivery.
Direct peers
- MindPath Health: Outpatient psychiatric and behavioral health practice offering psychiatric evaluation, medication management, counseling, and TMS. Closely matches Solace's comprehensive outpatient service portfolio.
- Amen Clinics: Multi-location psychiatric practice specializing in brain imaging, TMS, and treatment-resistant depression. Comparable advanced-treatment stack and clinic-based delivery model.
- Greenbrook TMS: National provider of TMS therapy for depression and OCD across multiple U.S. states. Directly comparable as a multi-site TMS clinic operator with similar service mix and insurance billing model.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Solace Behavioral Health social profiles
Digital presenceSolace Behavioral Health compliance and trust
Trust signalCompliance1 record
Solace Behavioral Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Solace Behavioral Health leadership team
Management profileNumber of profiles
Solace Behavioral Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Solace Behavioral Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Solace Behavioral Health
What does Solace Behavioral Health do?
Solace Behavioral Health is a psychiatric practice operating three clinics in Florida that delivers outpatient mental health and addiction treatment. Core offerings include Transcranial Magnetic Stimulation (TMS) using NeuroStar and BrainsWay Deep TMS systems, Spravato (esketamine) intranasal therapy, IV Ketamine infusions, psychiatric evaluation and medication management, individual counseling across 20+ modalities, addiction treatment with MAT (Suboxone), detox consultation, an Intensive Outpatient Program (IOP), group therapy, and meditation guidance.
Is Solace Behavioral Health a public or private company?
Solace Behavioral Health is a private company. It is classified as unknown and is currently operating.
When was Solace Behavioral Health founded?
Solace Behavioral Health was founded in 2012. It employs 11 to 50 people.
Where is Solace Behavioral Health based?
Solace Behavioral Health is headquartered in Brooksville, United States, in the North America region.
How does Solace Behavioral Health make money?
Six revenue lines are on record. Psychiatric Services are the primary driver. The others are TMS Therapy, spravato Treatment, ketamine Therapy, counseling Services and addiction Treatment and IOP.
Who are Solace Behavioral Health's main competitors?
Regional players on record are Pasadena Recovery Center, Behavioral Health of the Palm Beaches and CenterPointe Health. Emerging players are Talkiatry, Charlie Health, Brightside Health and Cerebral. Direct peers are MindPath Health, Amen Clinics and Greenbrook TMS.
Does Solace Behavioral Health have an API?
No public API is recorded for Solace Behavioral Health.
What industry is Solace Behavioral Health in?
Solace Behavioral Health's product category is Behavioral Health Services. Its primary akta.pro industry code is HLAFABAD, Outpatient Substance Use Disorder (SUD) Treatment Programs, with a secondary code of HLAFACAG, Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs). Its NAICS code is 621420 and its SIC code is 8011.